If
one was so inclined, RNA-seq could be considered in the context of a
symphony. The first movement, as with Beethoven’s Symphony No. 5 in C
minor, started with an Allegro con brio, “with vigor”. The advent of
next generation sequencing empowered pioneers to look into the life of
cells with unprecedented resolution.
Details
of new species of RNA, allele specific expression, and more began to
emerge, with a new discovery almost every day. That we were only in the
first movement likewise became clear. How to prepare samples, what
platform to choose, how to work with the data, were questions without
easy answers. Just as conductors fought over the correct interpretation
of Beethoven’s score, so scientists brought their individual perspective
to RNA-seq.
Second
movements in symphonies are typically slower, but Beethoven chose an
Andante con moto, “with movement and certain quickness”, describing well
the state of RNA-seq today. Our field is moving forward deliberately
now, towards answers as to how best to use these new capabilities, with
exciting discoveries along the way.
And you have the opportunity to further your part in the symphony. I invite you to join me at RNA-Seq 2013 in Boston, June 18-20, 2013. You will hear from leaders using this technology to drive research and make decisions.
Presentations
will address sample prep methods, analysis methods, platform choices,
characterizing complicated expression patterns, choosing solution
providers, application to drug discovery and more. Add your voice to our
panel discussion on customizing analysis to meet your needs. Join us as
we move towards the next movement in RNA-seq.
I
understand that early registration closes in a month so book soon to
get the best prices. You can see the full agenda and speaker line up
here: www.rna-seqsummit.com.
I look forward to seeing you there.
Kind regards,
Paul
Paul Kayne
Senior Principal Scientist,
Head of Genomic Technologies
Bristol Myers-Squibb
| 
No comments:
Post a Comment